Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
mean decrease » a decrease (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
mean decrease » a decrease (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
101
-
102
-
103
Rare nsSNPs extracted on the basis of MAF and downstream functional effects of PTB-related genes.
Published 2023Subjects: -
104
-
105
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…Microscopic images of colonies were taken at ×40 magnification. The data represents mean values and standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”
-
106
-
107
-
108
-
109
Optogenetic stimulation of the hippocampal CA1 astrocytes does not significantly affect the expression of AMPA receptors or VGLUT2.
Published 2024“…Results are expressed as mean ± SD (<i>n</i> = 4). n.s., not significant (one-way ANOVA). Source data can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002687#pbio.3002687.s025" target="_blank">S1 Data</a>.…”
-
110
LCN2 treatment does not significantly alter the membrane expression of AMPA receptors or VGLUT2 in the hippocampal neurons.
Published 2024“…*<i>p</i> < 0.05 between the indicated groups; n.s., not significant (one-way ANOVA). (<b>C</b>) Western blot analysis of GLUR1 or GLUR2 present in SPM obtained from the hippocampal neurons after glycine treatment. …”
-
111
-
112
-
113
-
114
-
115
-
116
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
117
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
118
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
119
Summary table showing analysis of randomized controlled trials stratified based on age groups.
Published 2025Subjects: -
120